(Oslo, 14th of April 2026) Medistim ASA (OSE: MEDI), a niche market leader within ultrasound technology with headquarter in Norway, that develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery, announces that the Board of Medistim ASA has approved the Financial Statements for 2025. The Financial Statements are without changes from the preliminary Financial Statements published on the 27th of February 2026. The annual report for 2025 is now available.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Kari E.
Contact Kari E., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack